<DOC>
	<DOCNO>NCT01601327</DOCNO>
	<brief_summary>The aim present study demonstrate influence three different treatment strategy biochemical parameter testicular volume ( TV ) patient idiopathic hypogonadotropic hypogonadism ( IHH ) .</brief_summary>
	<brief_title>Effects Medications Patients With Hypogonadism</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>hypogonadotropic hypogonadism decrease serum testosterone concentration normal range ( serum T &lt; 300ng/dL ) , FSH LH level within normal range , absence pituitary hypothalamic mass lesion MRI , presence gonadotropin response repetitive dos GnRH , normal smell test normal karyotype previous androgen treatment , history smoking , presence bilateral anorchia , intellectual deficiency , diabetes mellitus , arterial hypertension dyslipoproteinemia , medication kind drug abuse . Because possible confounding effect , patient hormone deficiency exclude . Participants iron , vitamin B12 folate deficiency also exclude .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>treatment</keyword>
	<keyword>testis volume</keyword>
</DOC>